Left Atrial Posterior Wall Additional Isolation for Persistent Atrial Fibrillation Trial

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It enrolled 276 participants.

Also called NCT04405258

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 276 participants (enrolled count) (from the registry)
Sponsor
Institute for Clinical Effectiveness, Japan (from the registry)
Registry
  • NCT NCT04405258
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Japan (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT04405258. Randomized; single masking; primary purpose treatment. Start 2020-06-08 (actual); primary completion 2025-12-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Left Atrial Posterior Wall Additional Isolation for Persistent Atrial Fibrillation Trial
Acronym
LEAP-AF
Condition
Persistent Atrial Fibrillation
Condition
Pulmonary Vein Isolation
Condition
Posterior Wall Isolation
Intervention (Procedure)
Pulmonary vein isolation
Intervention (Procedure)
Left posterior wall isolation
Lead sponsor
Institute for Clinical Effectiveness, Japan (class: other)

Record details

Record id
cardio:ct-nct04405258
Content hash
b334017c4c9ebb4393a4b54d219efcadbdc363dcc9f4cb4385dfd79a92b1db9a